Most hospice technology decisions get made reactively. A location has a recurring pharmacy delay, so leadership buys a point solution for that specific problem. A new site comes on through acquisition, so it gets whatever system its prior owner used, bolted onto the parent organization's existing stack. Over a few years, this produces exactly what it sounds like: a patchwork of systems that don't talk to each other, each solving a narrow problem while creating a bigger one.
A real roadmap works differently. Instead of reacting to whichever problem is loudest, it starts from where the organization wants to be in two or three years and sequences investments so each one builds toward that state rather than away from it.
The cost of this pattern isn't always obvious in the moment. Each point solution seems justified on its own, and the organization rarely stops to add up what it's spending in total, or how much staff time goes into keeping several disconnected systems reconciled with each other. By the time leadership notices the pattern, the organization is often managing a collection of systems that were each a reasonable answer to a narrow question.
Once those questions are answered honestly, sequencing becomes clearer. Connected medication ordering and EMR integration are often a logical place to start because they can establish a more consistent source of medication data. Cost visibility and formulary control can then build on that foundation. Multi-location standardization becomes more effective once the underlying workflows and data are consistent.
This is also where a roadmap earns its name. A list of technology purchases isn't a roadmap. A sequence where each step makes the next one easier to implement.
It's worth being explicit about why this order matters rather than just asserting it. Cost visibility built on top of inconsistent ordering data produces reports leadership can't fully trust, and standardizing a workflow before it's connected to accurate medication data just locks in the same errors at every location simultaneously. Sequencing isn't a formality. It determines whether each later investment actually works as intended.
BetterRX's EMR integrations are built in-house and maintained in partnership with each EMR, which means medication data connects to the organization's existing patient records helping minimize dual entry and streamline orders. That's the foundation most roadmaps need first.
From there, Operational Excellence Standardization is the piece that lets the roadmap hold up under growth. As new locations are added, BetterRX helps standardize workflows, embed organizational standards, and provide real-time visibility across the organization without multiplying complexity.
A common mistake is treating the roadmap as a one-time planning exercise rather than a living document. Hospice organizations that get the most value from their roadmap revisit it at least annually, checking three things:
It's easy to describe a roadmap in the abstract. It's more useful to describe what changes once one is actually in place. A hospice organization with a mature technology roadmap can extend standardized workflows to newly acquired locations without multiplying complexity. Leadership can see cost and utilization data for every location in the same dashboard, on the same day, rather than waiting for each site to catch up to a common reporting standard.
That's the real test of whether a roadmap is working: not whether every technology decision was made correctly in isolation, but whether the organization's tenth location is measurably easier to bring on than its second one was.
Even organizations that build a thoughtful roadmap can lose ground to a few recurring mistakes.